MarketCapTrends
PTCT
PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare

PTC Therapeutics, Inc. Shareholder Equity 2011–2025

PTC Therapeutics, Inc. annual/quarterly shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • PTC Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were -205.3M, a 81.30% decrease year-over-year.
  • PTC Therapeutics, Inc. shareholder equity for 2025 were -205.3M, a 81.30% decrease from 2024.
  • PTC Therapeutics, Inc. shareholder equity for 2024 were -1.10B, a 34.15% increase from 2023.
  • PTC Therapeutics, Inc. shareholder equity for 2023 were -818.6M, a 135.84% increase from 2022.
  • PTC Therapeutics, Inc. shareholder equity for 2022 were -347.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
PTC Therapeutics, Inc. Annual Shareholder Equity (Millions of US $)
2025$-205
2024$-1,098
2023$-819
2022$-347
2021$1
2020$482
2019$594
2018$351
2017$156
2016$120
2015$226
2014$298
2013$137
2012$-100
PTC Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$-205
2024-12-31$-1,098
2023-12-31$-819
2022-12-31$-347
2021-12-31$1
2020-12-31$482
2019-12-31$594
2018-12-31$351
2017-12-31$156
2016-12-31$120
2015-12-31$226
2014-12-31$298
2013-12-31$137
2012-12-31$-100

Ptc Therapeutics Inc. Shareholder Equity — FAQ

Ptc Therapeutics Inc. (PTCT) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PTCT's shareholder equity history?

The chart and table above show Ptc Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.